Pemetrexed alone or in combination with cisplatin in previously treated patients with malignant pleural mesothelioma (MPM): Outcomes of an expanded access program (EAP).

被引：0
|
作者：
Orlando, M
Wozniak, A
Janne, P
Belani, CP
Keohan, ML
Ross, H
Polikoff, J
Mintzer, D
Bloss, L
Obasaju, C
机构：
[1] Lilly Res Labs, Indianapolis, IN USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Columbia Presbyterian Med Ctr, New York, NY 10032 USA
[5] Oregon Hlth Sci Univ, Portland, OR 97201 USA
[6] Kaiser Hosp San Diego, San Diego, CA USA
[7] Penn Hosp, Philadelphia, PA 19107 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7195
引用
收藏
页码：664S / 664S
页数：1
相关论文
共 50 条
  • [21] Pemetrexed plus Carboplatin or Cisplatin as Neoadjuvant Treatment of Operable Malignant Pleural Mesothelioma (MPM)
    Pasello, Giulia
    Marulli, Giuseppe
    Polo, Valentina
    Breda, Cristiano
    Bonanno, Laura
    Loreggian, Lucio
    Rea, Federico
    Favaretto, Adolfo
    ANTICANCER RESEARCH, 2012, 32 (12) : 5393 - 5399
  • [22] Outcomes of patients with malignant pleural mesothelioma treated with first line palliative cisplatin and pemetrexed chemotherapy, in South Yorkshire
    Taylor, F.
    Viggars, A.
    Daniels, S.
    Danson, S. J.
    Fisher, P. M.
    Hatton, M. Q.
    Lee, C. E.
    Woll, P. J.
    LUNG CANCER, 2015, 87 : S20 - S20
  • [23] Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent
    Carteni, G.
    Manegold, C.
    Martin Garcia, G.
    Siena, S.
    Zielinski, C. C.
    Amadori, D.
    Liu, Y.
    Blatter, J.
    Visseren-Grul, C.
    Stahel, R.
    LUNG CANCER, 2009, 64 (02) : 211 - 218
  • [24] Single-agent pemetrexed for chemonaive and pretreated patients with malignant pleural mesothelioma - Results of an International Expanded Access Program
    Taylor, Paul
    Castagneto, Bruno
    Dark, Graham
    Marangolo, Maurizio
    Scagliotti, Giorgio V.
    van Klaveren, Rob J.
    Labianca, Roberto
    Serke, Monika
    Schuette, W.
    van Meerbeeck, Jan P.
    Heigener, David
    Liu, Yushan
    Adachi, Susumu
    Blatter, Johannes
    von Pawel, Joachim
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (07) : 764 - 771
  • [25] THE RETROSPECTIVE STUDY OF RE-CHALLENGE MALIGNANT PLEURAL MESOTHELIOMA PATIENTS PREVIOUSLY TREATED WITH PEMETREXED
    Mikami, Koji
    Koda, Yuichi
    Fujimoto, Eriko
    Negi, Yoshiki
    Horio, Daisuke
    Kanemura, Shingo
    Shibata, Eisuke
    Okuwa, Hisaya
    Kamiya, Hitomi
    Honda, Miki
    Masachika, Eriko
    Otsuki, Taiichiro
    Maeda, Risa
    Nogi, Yoshitaka
    Terada, Takayuki
    Tamura, Kunihiro
    Tabata, Chiharu
    Nakano, Takashi
    RESPIROLOGY, 2013, 18 : 92 - 92
  • [26] Combination Chemotherapy with Cisplatin, Pemetrexed, and Nivolumab for Malignant Pleural Mesothelioma: A Trial in Progress
    Fujimoto, N.
    Aoe, K.
    Kozuki, T.
    Oze, I.
    Kato, K.
    Kishimoto, T.
    Hotta, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S746 - S746
  • [27] Pemetrexed in combination with carboplatin in elderly patients with malignant pleural mesothelioma
    Ceresoli, G. L.
    Castagneto, B.
    Zucali, P. A.
    Favaretto, A. G.
    Mencoboni, M.
    De Giovanni, D.
    Cortinovis, D.
    Marangolo, M.
    Grossi, F.
    Del Conte, G.
    Ceribelli, A.
    Bearz, A.
    Muzio, A.
    Santoro, A.
    LUNG CANCER, 2006, 54 : S46 - S46
  • [28] PEMETREXED IN COMBINATION WITH CARBOPLATIN IN THE TREATMENT OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA
    Pasquini, E.
    Papi, M.
    Drudi, F.
    Tamburini, E.
    Genestreti, G.
    Nicoletti, S.
    Arcangeli, V
    Nicolini, M.
    Fabbri, P.
    Santo, A.
    Gianni, L.
    Fantini, M.
    Ravaioli, A.
    ANNALS OF ONCOLOGY, 2009, 20
  • [29] Irinotecan in combination with gemcitabine as second-line chemotherapy in patients with malignant pleural mesothelioma previously treated with pemetrexed-cisplatin regimen: a phase 2 study
    Fukuoka, Kazuya
    Nakano, Takashi
    Kuribayashi, Kozo
    Iida, Shin-ichiro
    Tamura, Kunihiro
    Tabata, Chiharu
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S771 - S771
  • [30] Open-label study of pemetrexed (P) alone or in combination with a platinum in patients (pts) with peritoneal mesothelioma (PM): results from the international expanded access program (EAP)
    Carteni, G.
    Manegold, C.
    Garcia, G. Martin
    Siena, S.
    Zielinski, C. C.
    Amadori, D.
    Liu, Y.
    Visseren-Grul, C.
    Blatter, J.
    Stahel, R.
    EJC SUPPLEMENTS, 2007, 5 (04): : 379 - 380
12345